PubMed HealthSearch

PubMed · 322599

Cardiac dynamics.

Abstract

The studies reported here were selected because of renewed interest in these areas, particularly as they relate to the evaluation and management of patients with coronary artery disease and heart failure. The first section emphasized a new conceptual approach to changes in the diastolic pressure-volume relation of the left ventricle. Although previous studies have concentrated on mathematical models which describe wall stress and stiffness as derived from the pressure-volume relationship, this review emphasizes that hemodynamic factors are very important in acutely altering the pressure-volume relationship of the left ventricle. This is partly due to alterations in right ventricular pressure, which subsequently influence the left ventricular pressure-volume relationship. In addition, recent studies have pointed out that compliance indices measured at low end-diastolic pressures differ from the indices measured at high end-diastolic pressures, so that limited information from one portion of the curve may not be generalized to describe the entire curve. The section on afterload emphasized the importance of this factor in influencing cardiac function, particularly in the presence of heart failure. In patients with both acute and chronic heart failure, vasodilator drugs which reduce ventricular afterload have produced substantial hemodynamic benefit by reducing the filling pressures of the right and left ventricles and increasing forward cardiac output. This hemodynamic improvement in response to afterload reduction is predictable from the different quantitative descriptions of ventricular afterload. Nevertheless, it is still unclear which method best describes afterload. Although wall stress, impedance, vascular resistance, and aortic pressure have all been utilized as a measure of afterload, each has some shortcomings which may limit its applicability. The final section reviewed approaches to the measurement of regionally ischemic myocardium. Since current studies have emphasized the importance of identifying and preserving ischemic, but viable, myocardium, this section has reviewed techniques for measuring local mechanical performance. Previous studies with the Walton-Brodie strain gauge and epicardial length gauge did not appear to be as satisfactory as more recent measurements with ultrasonic crystals, which can simultaneously measure wall thickness and segment length. These methods form the basis for ongoing experiments designed to evaluate approaches for preserving ischemic myocardium in the setting of experimental myocardial infarction.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W W Parmley, J V Tyberg, S A Glantz. 1977. Cardiac dynamics.. https://doi.org/10.1146/annurev.ph.39.030177.001425

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Comparison of painful and painless left ventricular dysfunction recorded during ambulatory ventricular function monitoring in angina pectoris secondary to coronary artery disease.

Left ventricular (LV) function and the electrocardiogram of 55 patients with coronary artery disease and angina were monitored for a mean of 3.2 +/- 1.9 hours with an ambulatory LV function monitor. During the monitoring interval, patients performed daily activities such as sitting, walking, climbing stairs, and eating. Sixty episodes of transient reduction in ejection fraction of > 5% lasting > 60 seconds were observed in 24 patients; 13 episodes were associated with typical angina, but 47 were asymptomatic. Asymptomatic episodes had a shorter duration of ventricular dysfunction (116 +/- 49 vs 189 +/- 113 seconds; p < 0.05), and smaller increases in relative end-diastolic and end-systolic volumes (end-diastolic 0.9 +/- 5.4% vs 4.6 +/- 4.9% [p < 0.05], and end-systolic 21 +/- 11% vs 35 +/- 20% [p < 0.05]) than did symptomatic ones. When a subset of patients with both symptomatic and asymptomatic episodes were analyzed, similar results were observed: in asymptomatic episodes, duration was shorter (82 +/- 31 vs 200 +/- 110 seconds; p < 0.005), ejection fraction decrease was smaller (-7.3 +/- 2.6% vs -11.0 +/- 4.7%; p < 0.05), and end-systolic volume increase was smaller (23 +/- 12% vs 37 +/- 19%; p < 0.05). The data suggest that asymptomatic transient LV dysfunction is less severe and of shorter duration in patients with angina pectoris.

Angina Pectoris

[Angina pectoris after sumatriptan (Imigran)].

Developed for the treatment of migraine, sumatriptan is an agonist of 5-hydroxytryptamine-1-receptors. Though a pressure sensation is a common complaint, significant ECG changes have not been reported after subcutaneous administration of sumatriptan. A case history is given where angina pectoris after sumatriptan self-administration was experienced on two occasions by a 61-year old man with a history of minor myocardial infarction--without post-infarction angina--two years previously. The angina after sumatriptan was accompanied on both occasions by significant ST-segment depression on ECG-monitoring. An extracranial vasoconstrictor action of sumatriptan in patients with ischaemic heart disease is suggested.

Angina Pectoris